| Repurposing disulfiram for targeting of glioblastoma stem cells: An in vitro study L Zirjacks, N Stransky, L Klumpp, L Prause, F Eckert, D Zips, S Schleicher, ... Biomolecules 11 (11), 1561, 2021 | 13 | 2021 |
| Patient‐individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis K Ganser, F Eckert, A Riedel, N Stransky, F Paulsen, S Noell, M Krueger, ... International Journal of Cancer 150 (10), 1722-1733, 2022 | 9 | 2022 |
| Against repurposing methadone for glioblastoma therapy T Vatter, L Klumpp, K Ganser, N Stransky, D Zips, F Eckert, SM Huber Biomolecules 10 (6), 917, 2020 | 8 | 2020 |
| Ten simple rules for implementing open and reproducible research practices after attending a training course V Heise, C Holman, H Lo, EM Lyras, MC Adkins, MRJ Aquino, ... PLOS Computational Biology 19 (1), e1010750, 2023 | 6 | 2023 |
| Can any drug be repurposed for cancer treatment? A systematic assessment of the scientific literature N Stransky, P Ruth, M Schwab, MW Löffler Cancers 13 (24), 6236, 2021 | 6 | 2021 |
| Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model N Stransky, K Ganser, L Quintanilla-Martinez, I Gonzalez-Menendez, ... Scientific Reports 13 (1), 20604, 2023 | 2 | 2023 |
| Ion channels as molecular targets of glioblastoma electrotherapy T Abed, K Ganser, F Eckert, N Stransky, SM Huber Frontiers in Cellular Neuroscience 17, 1133984, 2023 | 2 | 2023 |
| Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction N Stransky, K Ganser, U Naumann, SM Huber, P Ruth Cancers 14 (24), 6199, 2022 | 2 | 2022 |
| Potential of pre-operative MRI features in glioblastoma to predict for molecular stem cell subtype and patient overall survival F Eckert, K Ganser, B Bender, J Schittenhelm, M Skardelly, F Behling, ... Radiotherapy and Oncology 188, 109865, 2023 | 1 | 2023 |
| Comment on Chen et al. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin. Biomolecules 2021, 11, 1373 N Stransky, SM Huber Biomolecules 12 (4), 573, 2022 | 1 | 2022 |
| P03. 07. A MRI signature in preoperative imaging predicts mesenchymal stem cell features and radioresistance in primary glioblastoma stem cell cultures F Eckert, K Ganser, B Bender, J Schittenhelm, S Noell, N Stransky, ... Neuro-Oncology 24 (Suppl 2), ii33, 2022 | | 2022 |
| PH-0167 MRI features correlate with a molecular signature in glioblastoma stem cells F Eckert, K Ganser, N Stransky, B Bender, J Schittenhelm, S Noell, ... Radiotherapy and Oncology 161, S102-S103, 2021 | | 2021 |
| The Immune Checkpoint CD276 as a potential Target for the Eradication of mesenchymal Glioblastoma Cells N Stransky, K Ganser, M Spring, M Prause, L Klumpp, S Schleicher, ... STRAHLENTHERAPIE UND ONKOLOGIE 197 (SUPPL 1), S52-S52, 2021 | | 2021 |
| Tumor Volumes in MRI correlate with the molecular Signature of Glioblastoma Stem Cells in vitro F Eckert, K Ganser, N Stransky, B Bender, J Schittenhelm, S Noell, ... STRAHLENTHERAPIE UND ONKOLOGIE 197 (SUPPL 1), S45-S45, 2021 | | 2021 |
| Identification of a molecular Signature in primary Glioblastoma Stem Cells (pGSCs): Association with Radioresistance and Invasiveness in vitro and Growth Behavior in the … K Ganser, N Stransky, M Krueger, B Bender, J Schittenhelm, E Hoffmann, ... STRAHLENTHERAPIE UND ONKOLOGIE 197 (SUPPL 1), S78-S78, 2021 | | 2021 |
| Recurrence Pattern Analysis in Glioblastoma Patients: Predictive Parameters for the Occurrence of multilocular Recurrence E Hoffmann, L Klumpp, K Ganser, A Riedel, N Stransky, F Paulsen, D Zips, ... STRAHLENTHERAPIE UND ONKOLOGIE 196 (SUPPL 1), S126-S126, 2020 | | 2020 |
